Drug
Epoetin
Epoetin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_3
4
80%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 34 (80.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
NCT00077597
completedphase_3
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
NCT01478971
completedphase_3
A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.
NCT00546481
unknownphase_1
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth
NCT00491413
completedphase_3
Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
NCT00322413
Clinical Trials (5)
Showing 5 of 5 trials
NCT00077597Phase 3
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
NCT01478971Phase 3
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
NCT00546481Phase 3
A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.
NCT00491413Phase 1
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth
NCT00322413Phase 3
Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5